Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 92

1.

Oxidative stress in vascular disease and its pharmacological prevention.

Li H, Horke S, Förstermann U.

Trends Pharmacol Sci. 2013 Jun;34(6):313-9. doi: 10.1016/j.tips.2013.03.007. Review.

PMID:
23608227
2.

Nitric oxide and oxidative stress in vascular disease.

Förstermann U.

Pflugers Arch. 2010 May;459(6):923-39. doi: 10.1007/s00424-010-0808-2. Review.

PMID:
20306272
3.

Uncoupling of endothelial NO synthase in atherosclerosis and vascular disease.

Li H, Förstermann U.

Curr Opin Pharmacol. 2013 Apr;13(2):161-7. doi: 10.1016/j.coph.2013.01.006. Review.

PMID:
23395155
4.

Oxidative stress in vascular disease: causes, defense mechanisms and potential therapies.

Förstermann U.

Nat Clin Pract Cardiovasc Med. 2008 Jun;5(6):338-49. doi: 10.1038/ncpcardio1211. Review.

PMID:
18461048
5.

Pharmacological prevention of eNOS uncoupling.

Li H, Forstermann U.

Curr Pharm Des. 2014;20(22):3595-606. Review.

PMID:
24180386
6.

Toxicological and pharmacological concerns on oxidative stress and related diseases.

Saeidnia S, Abdollahi M.

Toxicol Appl Pharmacol. 2013 Dec 15;273(3):442-55. doi: 10.1016/j.taap.2013.09.031. Review.

PMID:
24121054
7.

Targeting NADPH oxidases in vascular pharmacology.

Schramm A, Matusik P, Osmenda G, Guzik TJ.

Vascul Pharmacol. 2012 May-Jun;56(5-6):216-31. doi: 10.1016/j.vph.2012.02.012. Review.

8.

Vascular oxidative stress, nitric oxide and atherosclerosis.

Li H, Horke S, Förstermann U.

Atherosclerosis. 2014 Nov;237(1):208-19. doi: 10.1016/j.atherosclerosis.2014.09.001. Review.

PMID:
25244505
9.

Is oxidative stress a therapeutic target in cardiovascular disease?

Münzel T, Gori T, Bruno RM, Taddei S.

Eur Heart J. 2010 Nov;31(22):2741-8. doi: 10.1093/eurheartj/ehq396. Review.

PMID:
20974801
10.

Vascular dysfunction in experimental diabetes is improved by pentaerithrityl tetranitrate but not isosorbide-5-mononitrate therapy.

Schuhmacher S, Oelze M, Bollmann F, Kleinert H, Otto C, Heeren T, Steven S, Hausding M, Knorr M, Pautz A, Reifenberg K, Schulz E, Gori T, Wenzel P, Münzel T, Daiber A.

Diabetes. 2011 Oct;60(10):2608-16. doi: 10.2337/db10-1395.

11.

Vascular NADPH oxidases as drug targets for novel antioxidant strategies.

Guzik TJ, Harrison DG.

Drug Discov Today. 2006 Jun;11(11-12):524-33. Review.

PMID:
16713904
12.

Novel therapeutic approaches in limiting oxidative stress and inflammation.

Spychalowicz A, Wilk G, Śliwa T, Ludew D, Guzik TJ.

Curr Pharm Biotechnol. 2012 Oct;13(13):2456-66. Review.

PMID:
22280420
14.

Strategies to reduce oxidative stress in cardiovascular disease.

Hamilton CA, Miller WH, Al-Benna S, Brosnan MJ, Drummond RD, McBride MW, Dominiczak AF.

Clin Sci (Lond). 2004 Mar;106(3):219-34. Review.

PMID:
14733610
15.

Resveratrol reverses endothelial nitric-oxide synthase uncoupling in apolipoprotein E knockout mice.

Xia N, Daiber A, Habermeier A, Closs EI, Thum T, Spanier G, Lu Q, Oelze M, Torzewski M, Lackner KJ, Münzel T, Förstermann U, Li H.

J Pharmacol Exp Ther. 2010 Oct;335(1):149-54. doi: 10.1124/jpet.110.168724.

16.

The uremic solute indoxyl sulfate induces oxidative stress in endothelial cells.

Dou L, Jourde-Chiche N, Faure V, Cerini C, Berland Y, Dignat-George F, Brunet P.

J Thromb Haemost. 2007 Jun;5(6):1302-8.

17.

Antioxidant vitamins C and E ameliorate hyperglycaemia-induced oxidative stress in coronary endothelial cells.

Ulker S, McMaster D, McKeown PP, Bayraktutan U.

Diabetes Obes Metab. 2004 Nov;6(6):442-51.

PMID:
15479220
18.

Therapeutic effect of enhancing endothelial nitric oxide synthase (eNOS) expression and preventing eNOS uncoupling.

Förstermann U, Li H.

Br J Pharmacol. 2011 Sep;164(2):213-23. doi: 10.1111/j.1476-5381.2010.01196.x. Review.

19.

Regulation of antioxidant and oxidant enzymes in vascular cells and implications for vascular disease.

Wassmann S, Wassmann K, Nickenig G.

Curr Hypertens Rep. 2006 Apr;8(1):69-78. Review.

PMID:
16600162
20.

Oxidative stress and mitochondrial dysfunction in atherosclerosis: mitochondria-targeted antioxidants as potential therapy.

Victor VM, Apostolova N, Herance R, Hernandez-Mijares A, Rocha M.

Curr Med Chem. 2009;16(35):4654-67. Review.

PMID:
19903143

Supplemental Content

Support Center